Binding and cytotoxicity of ¹³¹I-labeled gastrin-releasing peptide receptor antagonists modified by cell penetrating peptides

Gastrin releasing peptide receptors (GRPRs) are one of the most interesting targets over expressed in various tumors. Due to the superior potential of the GRPR antagonist analogs, they have been studied in the tumor radio imaging and therapy field. However, typical antagonists suffered the shortcomings of no internalization and poor binding affinity which hampered their applications in radiotherapy. Therefore, we attempted to introduce Oligoarginines (cell penetrating peptides) to RM26, aiming to increase the binding affinity or even trigger the internalization of the peptides on cells. The results showed Arg₆ as the most potent CPP, significantly enhanced the binding avidity of RM26 to the GRPR. (author)